Nigel L. Webb
12Patents
10h-index
8Co-inventors
61Inventor score
Filing activity: May 22, 1996 → Jul 11, 2014
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US5795909A | DHA-pharmaceutical agent conjugates of taxanes | Human Necessities | 197 | Expired |
| US5919815A | Taxane compounds and compositions | Human Necessities | 111 | Expired |
| US5977174A | Cholinergic compositions and uses thereof | Human Necessities | 56 | Expired |
| US6080877A | Taxanes | Human Necessities | 54 | Expired |
| US6602902B2 | Dha-pharmaceutical agent conjugates to improve tissue selectivity | Human Necessities | 52 | Expired |
| US6576636B2 | Method of treating a liver disorder with fatty acid-antiviral agent conjugates | Human Necessities | 43 | Expired |
| US6197764A | Clozapine compositions and uses thereof | Human Necessities | 37 | Expired |
| US5955459A | Fatty acid-antipsychotic compositions and uses thereof | Human Necessities | 33 | Expired |
| US7235583B1 | Fatty acid-anticancer conjugates and uses thereof | Human Necessities | 22 | Expired |
| US7199151B2 | DHA-pharmaceutical agent conjugates of taxanes | Human Necessities | 19 | Expired |
| US8314077B2 | Fatty acid-pharmaceutical agent conjugates | Human Necessities | 6 | Expired |
| US9403974B2 | Clay/polymer blend as high pH or ionic liquid barrier | Emerging Cross-Sectional Technologies | 1 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.